1. Carpanelli C, Gaiani G, Albini A. Alchoolysis of N,N`

1. Carpanelli C, Gaiani G, Albini A. Alchoolysis of N,N`

Dr. Adriana Albini
List of Pubblications
(IF from 1991)
1. Carpanelli C, Gaiani G, Albini A. Alchoolysis of N,N'-Dyaryl–sulphur-diimides. Gazz Chim
Ital. 112:409-14; 1982.
2. Parodi S, Pala M, Russo P, Zunino A, Balbi C, Albini A, Valerio F, Cimberle MR, Santi L.
DNA damage in liver, kidney, bone marrow, and spleen of rats and mice treated with
commercial and purified aniline as determined by alkaline elution assay and sister chromatid
exchange induction. Cancer Res. 42:2277-83.; 1982.
3. Parodi S, Santi L, Russo P, Albini A, Vecchio D, Pala M, Ottaggio L, Carbone A. DNA
damage induced by auramine O in liver, kidney, and bone marrow of rats and mice, and in a
human cell line (alkaline elution assay and SCE induction). J Toxicol Environ Health. 9:94152.; 1982.
4. Albini A, Pontz B, Mensing H, Cantz M, Muller PK. [Chemotactic activity of fibroblasts in
mucopolysaccharidoses]. Padiatr Padol. 18:263-7; 1983.
5. Albini A, Richter H, Pontz BF. Localization of the chemotactic domain in fibronectin. FEBS
Lett. 156:222-6.; 1983.
6. Albini A, Muller PK, Parodi S. A method to select cell populations with enhanced chemotactic
activity. Biosci Rep. 4:311-8.; 1984.
7. Allavena G, Albini A, Parodi S. Chemotactic response of SV40 virus transformed fibroblasts to
conditioned medium: dependence on time and cell number. Boll Soc Ital Biol Sper. 60:236975.; 1984.
8. Mensing H, Albini A, Krieg T, Pontz BF, Muller PK. Enhanced chemotaxis of tumor-derived
and virus-transformed cells to fibronectin and fibroblast-conditioned medium. Int J Cancer.
33:43-8.; 1984.
9. Pontz BF, Albini A, Mensing H, Cantz M, Muller PK. Pattern of collagen synthesis and
chemotactic response of fibroblasts derived from mucopolysaccharidosis patients. Exp Cell Res.
155:457-66.; 1984.
10. Albini A, Adelmann-Grill BC. Collagenolytic cleavage products of collagen type I as
chemoattractants for human dermal fibroblasts. Eur J Cell Biol. 36:104-7.; 1985.
11. Albini A, Adelmann-Grill BC, Muller PK. Fibroblast chemotaxis. Coll Relat Res. 5:283-96.;
1985.
12. Allavena G, Melchiori A, Carlone S, Parodi S, Renzo MFD, Albini A. Changeable chemotactic
response of metastatic variant lines of RSV-transformed mouse fibroblasts. Cell Biol Int Rep.
10:191; 1986.
13. Albini A, Allavena G, Richter H, Pontz BF, Parodi S, Santi L. SV40 transformed fibroblasts
recognize the same 140 kD fibronectin chemotactic fragment as non-transformed cells.
Experientia. 41:1591-3.; 1985.
14. Albini A, Krieg T, Schmoeckel C, Weber L, Mueller P. Dermatofibrosarcoma protuberans:
altered collagen metabolism in cell culture. J Invest Dermatol. 85:381-4.; 1985.
15. Schmoeckel C, Albini A, Krieg T, Stets R. The fibroblastic nature of dermatofibrosarcoma
protuberans: morphological investigations in vivo and in vitro. Arch Dermatol Res. 278:138-47;
1985.
16. Albini A, Graf J, Kitten GT, Kleinman HK, Martin GR, Veillette A, Lippman ME. 17 betaestradiol regulates and v-Ha-ras transfection constitutively enhances MCF7 breast cancer cell
interactions with basement membrane. Proc Natl Acad Sci U S A. 83:8182-6.; 1986.
17. Allavena G, Melchiori A, Carlone S, Parodi S, Renzo MFD, Albini A. Changeable chemotactic
response of metastatic variant lines of RSV-transformed mouse fibroblasts. Cell Biol Int Rep.
10:191; 1986.
18. Melchiori A, Allavena G, Negrone R, Parodi S, Albini A. Effect of different cell detachment
techniques on fibroblast chemotaxis to fibronectin and conditioned medium. Boll Soc Ital Biol
Sper. 62:637-43.; 1986.
19. Albini A, Allavena G, Melchiori A, Giancotti F, Richter H, Comoglio PM, Parodi S, Martin
GR, Tarone G. Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cellattachment site in fibronectin and a fibronectin cell surface receptor. J Cell Biol. 105:1867-72.;
1987.
20. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN.
A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res.
47:3239-45.; 1987.
21. Aresu O, Allavena G, Melchiori A, Parodi S, D'Amore E, Olivieri GB, Nicolo G, Schmidt J,
Albini A. Chemotactic activity "in vitro" and transplantability in isogenic mice of radionuclideinduced murine osteosarcomas. Boll Soc Ital Biol Sper. 63:435-41.; 1987.
22. Melchiori A, Allavena G, Bohm J, Remy W, Schmidt J, Parodi S, Santi L, Albini A. Interferons
inhibit chemotaxis of transformed cells and their invasion of a reconstituted basement
membrane. Anticancer Res. 7:475-9.; 1987.
23. Albini A, Mitchell CD, Thompson EW, Seeman R, Martin GR, Wittek AE, Quinnan GV.
Invasive activity and chemotactic response to growth factors by Kaposi's sarcoma cells. J Cell
Biochem. 36:369-76.; 1988.
24. Albini A, Pontz B, Pulz M, Allavena G, Mensing H, Muller PK. Decline of fibroblast
chemotaxis with age of donor and cell passage number. Coll Relat Res. 8:23-37.; 1988.
25. Allavena G, Melchiori A, Aresu O, Ferreri-Santi L, McEwan R, Kitten G, Parodi S, Albini A.
"In vitro" models for studying the malignant phenotype: chemotaxis and chemoinvasion. Adv
Exp Med Biol. 233:215-26; 1988.
26. Allavena G, Melchiori A, Carlone S, Di Renzo MF, Comoglio P, Parodi S, Santi L, Albini A.
High chemotactic motility and growth in hard agar of a variant of RSV- transformed fibroblasts
are lost in late passages. Tumori. 74:1-6.; 1988.
27. Thompson E, Reich R, Martin GR, Albini A. Factors regulation basement membrane invasion
by tumor cells. In: Lippman ME, Dickson RB, editors. Breast Cancer: Cellular and Molecular
Biology; 1988. p. 239-49.
28. Thompson EW, Reich R, Martin GR, Albini A. Factors regulating basement membrane
invasion by tumor cells. Cancer Treat Res. 40:239-49; 1988.
29. Thompson EW, Reich R, Shima TB, Albini A, Graf J, Martin GR, Dickson RB, Lippman ME.
Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by
antiestrogens. Cancer Res. 48:6764-8.; 1988.
30. Albini A, Aukerman SL, Ogle RC, Noonan DM, Fridman R, Martin GR, Fidler IJ. The in vitro
invasiveness and interactions with laminin of K-1735 melanoma cells. Evidence for different
laminin-binding affinities in high and low metastatic variants. Clin Exp Metastasis. 7:437-51.;
1989.
31. Inouye LN, Albini A, Chader GJ, Redmond TM, Nickerson JM. mRNA for interphotoreceptor
retinoid-binding protein (IRBP): distribution and size diversity in vertebrate species. Exp Eye
Res. 49:171-80.; 1989.
32. Percario M, Melchiori A, Aresu O, Ferreri-Santi L, Carlone S, Parodi S, Conio M, Munizzi F,
Aste H, Albini A, et al. Growth of cells from esophageal squamous cell carcinoma biopsies in a
reconstituted basement membrane. Boll Soc Ital Biol Sper. 65:775-81.; 1989.
33. Albini A, Toffenetti J, Zhu Z, Chader GJ, Noonan DM. Hypomethylation of the
interphotoreceptor retinoid-binding protein (IRBP) promotor and first exon is linked to
expression of the gene. Nucleic Acids Res. 18:5181-7.; 1990.
34. Colacci A, Perocco P, Vaccari M, Mazzullo M, Albini A, Parodi S, Taningher M, Grilli S. In
vitro transformation of BALB/c 3T3 cells by 1,1,2,2- tetrachloroethane. Jpn J Cancer Res.
81:786-92.; 1990.
35. Melchiori A, Carlone S, Allavena G, Aresu O, Parodi S, Aaronson SA, Albini A. Invasiveness
and chemotactic activity of oncogene transformed NIH/3T3 cells. Anticancer Res. 10:37-44.;
1990.
36. Albini A, Melchiori A, Santi L, Liotta LA, Brown PD, Stetler-Stevenson WG. Tumor cell
invasion inhibited by TIMP-2. J Natl Cancer Inst. 83:775-9.; 1991. IF=15,171
37. Aresu O, Nicolo G, Allavena G, Melchiori A, Schmidt J, Kopp JB, d'Amore E, Chader GJ,
Albini A. Invasive activity, spreading on and chemotactic response to laminin are properties of
high but not low metastatic mouse osteosarcoma cells. Invasion Metastasis. 11:2-13; 1991.
IF=1,438
38. Ochieng J, Basolo F, Albini A, Melchiori A, Watanabe H, Elliott J, Raz A, Parodi S, Russo J.
Increased invasive, chemotactic and locomotive abilities of c-Ha-ras- transformed human breast
epithelial cells. Invasion Metastasis. 11:38-47; 1991. IF=1,438
39. Thompson EW, Nakamura S, Shima TB, Melchiori A, Martin GR, Salahuddin SZ, Gallo RC,
Albini A. Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells
induce endothelial cell chemotaxis and invasiveness. Cancer Res. 51:2670-6.; 1991. IF=7,616
40. Wittek AE, Mitchell CD, Armstrong GR, Albini A, Martin GR, Seemann R, Levenbook IS,
Wierenga DE, Ridge J, Dunlap RC, Lundquist ML, Steis RG, Longo DL, Muller J, Jr GVQ.
Propagation and properties of Kaposi's sarcoma-derived cell lines obtained from patients with
AIDS: similarity of cultured cells to smooth muscle cells. Aids. 5:1485-93.; 1991. IF=5,835
41. Adatia R, Poggi L, Thompson EW, Gallo RC, Fassina GF, Albini A. Assessment of angiogenic
potential– The use of AIDS–KS cell supernatants as an in vitro model. In: Steiner R, Weisz PB,
Langer R, editors. Exs: Angiogenesis Key principles–Science– Tecnology–Medicine. Basel,
Boston, Berlin: Birchuser Verlag; 1992. p. 321–6.
42. Albini A, Melchiori A, Garofalo A, Noonan DM, Basolo F, Taraboletti G, Chader GJ, Gavazzi
R. Matrigel promotes retinoblastoma cell growth in vitro and in vivo. Int J Cancer. 52:234-40.;
1992. IF=4,700
43. Albini A, Noonan DM, Melchiori A, Fassina GF, Percario M, Gentleman S, Toffenetti J,
Chader GJ. Laminin-induced retinoblastoma cell differentiation: possible involvement of a 100kDa cell-surface laminin-binding protein. Proc Natl Acad Sci U S A. 89:2257-61.; 1992.
IF=10,231
44. Albini A, Repetto L, Carlone S, Benelli R, Gendelman R, Filippi PD, Bussolino F, Monaco L,
Soria M, Parravicini C. Characterization of Kaposi's sarcoma–derived cell cultures from an
epidemic and a classic case. Int J Oncol. 1:723–30; 1992. IF=2,681
45. Colacci A, Perocco P, Vaccari M, Lilingardi P, Vià CD, Giovanni CD, Lollini PL, Nanni P,
Nicoletti G, Albini A, Parodi S, Grilli S. In vitro assay of halogenated compounds transforming
activity as suitable model for studying multistep carcinogenesis. In: Kanduc D, Pani P, editors.
Carcinogenesis as Process. Bari; 1992. p. 71–6.
46. Melchiori A, Albini A, Ray JM, Stetler-Stevenson WG. Inhibition of tumor cell invasion by a
highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment.
Cancer Res. 52:2353-6.; 1992. IF=7,616
47. Melchiori A, Colacci A, Lollini PL, De Giovanni C, Carlone S, Grilli S, Parodi S, Albini A.
Induction of invasive and experimental metastasis potential in BALB/c 3T3 cells by
benzo(a)pyrene transformation. Invasion Metastasis. 12:1-11; 1992. IF=1,438
48. Adatia R, Albini A, Colacci A, De Giovanni C, Nanni P, Giunciuglio D, Parodi S, Grilli S,
Perocco P. Induction of chemotactic and invasive phenotype in BALB/c 3T3 cells by 1,2dibromoethane transformation. Invasion Metastasis. 13:234-43; 1993. IF=1,438
49. Albini A, Colacci A. Inhibition of malignant tumor cell invasion: an approach to antiprogression. Basic Life Sci. 61:335-50; 1993.
50. Albini A, Melchiori A, Parodi S, Kleinman HK. Chemotaxis and invasiveness. In: Lapiere C,
Krieg T, editors. Connective Tissue Diseases of the Skin. New York: Marcel Dekker, Inc.;
1993. p. 129–46.
51. Clerico L, Mancuso T, Noonan D, Albini A. Oncosuppressor genes: mechanisms of
inactivation for the retinoblastoma gene and p53. Boll Soc Ital Biol Sper. 69:725-34.; 1993.
52. Colacci A, Albini A, Melchiori A, Nanni P, Nicoletti G, Noonan D, Parodi S, Grilli S.
Induction of a malignant phenotype in BALB/c 3T3 cells by 1,1,2,2–tetrachloroethane. Int J
Oncol. 2:937–45; 1993. IF=2,681
53. Fassina G, Paglialunga G, Noonan DM, Chader GJ, Albini A. Modulation of Y–79
retinoblastoma and IRBP expression by dibutyryl cyclic AMP and laminin. Int J Oncol. 2:74551; 1993. IF=2,681
54. Mastroianni A, Invernizzi L, Tagliabue E, Fassina G, Albini A, Menard S, Colnaghi MI.
Alteration of laminin production in small-cell lung carcinoma: possible correlation with the
absence of the basement membrane. Tumour Biol. 14:279-87; 1993. IF=1,235
55. Albini A. Kaposi's sarcoma, vascular permeability, and scientific integrity [Letter]. Jama.
272:919-20; discussion 22-4.; 1994. IF=6,863
56. Albini A, Fontanini G, Masiello L, Tacchetti C, Bigini D, Luzzi P, Noonan DM, StetlerStevenson WG. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and
HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. Aids.
8:1237-44.; 1994. IF=5,835
57. Balzac F, Retta SF, Albini A, Melchiorri A, Koteliansky VE, Geuna M, Silengo L, Tarone G.
Expression of beta 1B integrin isoform in CHO cells results in a dominant negative effect on
cell adhesion and motility. J Cell Biol. 127:557-65.; 1994. IF=10,951
58. Barbanti-Brodano G, Sampaolesi R, Campioni D, Lazzarin L, Altavilla G, Possati L, Masiello
L, Benelli R, Albini A, Corallini A. HIV-1 tat acts as a growth factor and induces angiogenic
activity in BK virus/tat transgenic mice. Antibiot Chemother. 46:88-101; 1994.
59. Benelli R, Adatia R, Ensoli B, Stetler-Stevenson WG, Santi L, Albini A. Inhibition of AIDSKaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from
the metalloproteinase propeptide: implications for an anti-angiogenic therapy. Oncol Res.
6:251-7; 1994. IF=1,844
60. Benelli R, Repetto L, Carlone S, Parravicini C, Albini A. Establishment and characterization of
two new Kaposi's sarcoma cell cultures from an AIDS and a non-AIDS patient. Res Virol.
145:251-9.; 1994. IF=3,154
61. Gaetano C, Melchiori A, Albini A, Benelli R, Falcioni R, Modesti A, Modica A, Scarpa S,
Sacchi A. Retinoic acid negatively regulates beta 4 integrin expression and suppresses the
malignant phenotype in a Lewis lung carcinoma cell line. Clin Exp Metastasis. 12:63-72.; 1994.
IF=2,811
62. Sciacca FL, Sturzl M, Bussolino F, Sironi M, Brandstetter H, Zietz C, Zhou D, Matteucci C,
Peri G, Sozzani S, Benelli R, Arese M, Albini A, Colotta F, Mantovani A. Expression of
adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. J
Immunol. 153:4816-25; 1994. IF=6,387
63. Soldi R, Graziani A, Benelli R, Ghigo D, Bosia A, Albini A, Bussolino F. Oncostatin M
activates phosphatidylinositol-3-kinase in Kaposi's sarcoma cells. Oncogene. 9:2253-60.; 1994.
IF=6,872
64. Adatia R, Aluigi MG, Albini A. Biological Mechanisms of Invasion and Metastasis - Review.
Acta Medica Romana. 33:493–500; 1995.
65. Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B. Angiogenic properties of human
immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci U S A. 92:4838-42.; 1995.
IF=10,231
66. Albini A, D'Agostini F, Giunciuglio D, Paglieri I, Balansky R, De Flora S. Inhibition of
invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine.
Int J Cancer. 61:121-9.; 1995. IF=4,700
67. Bobola N, Hirsch E, Albini A, Altruda F, Noonan D, Ravazzolo R. A single cis-acting element
in a short promoter segment of the gene encoding the interphotoreceptor retinoid-binding
protein confers tissue- specific expression. J Biol Chem. 270:1289-94.; 1995. IF=5,854
68. Bussolino F, Arese M, Montrucchio G, Barra L, Primo L, Benelli R, Sanavio F, Aglietta M,
Ghigo D, Rola-Pleszczynski MR, Bosia A, Albini A, Camussi G. Platelet activating factor
produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J Clin
Invest. 96:940-52.; 1995. IF=15,053
69. De Flora S, Cesarone CF, Balansky RM, Albini A, D'Agostini F, Bennicelli C, Bagnasco M,
Camoirano A, Scatolini L, Rovida A, et al. Chemopreventive properties and mechanisms of NAcetylcysteine. The experimental background. J Cell Biochem Suppl. 22:33-41; 1995. IF=3,591
70. Descalzi Cancedda F, Melchiori A, Benelli R, Gentili C, Masiello L, Campanile G, Cancedda
R, Albini A. Production of angiogenesis inhibitors and stimulators is modulated by cultured
growth plate chondrocytes during in vitro differentiation: dependence on extracellular matrix
assembly. Eur J Cell Biol. 66:60-8.; 1995. IF=2,195
71. Fassina G, Paglialunga G, Perrotta A, Fontanini G, Cosimi A, Albini A. Type IV collagenase
and TIMP–2 mRNA. Expression in breast and lung carcinoma specimens. J Tumor Marker
Oncol. 10:41–3; 1995. IF=0,250
72. Giunciuglio D, Benelli R, Masiello L, Paglieri I, Pesarini A, Presta M, Noonan DM, Albini A.
Mechanisms of Kaposi's sarcoma cell supernatant–induced vascular cell invasion. Int J Oncol.
6:539–46; 1995. IF=2,681
73. Giunciuglio D, Cai T, Filanti C, Manduca P, Albini A. Effect of osteoblast supernatants on
cancer cell migration and invasion. Cancer Lett. 97:69-74.; 1995. IF=3,049
74. Giunciuglio D, Culty M, Fassina G, Masiello L, Melchiori A, Paglialunga G, Arand G,
Ciardiello F, Basolo F, Thompson EW, Albini A. Invasive phenotype of MCF10A cells
overexpressing c-Ha-ras and c-erbB-2 oncogenes. Int J Cancer. 63:815-22; 1995. IF=4,700
75. Melchiori A, Mortarini R, Carlone S, Marchisio PC, Anichini A, Noonan DM, Albini A. The
alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion. Exp Cell Res.
219:233-42.; 1995. IF=4,148.
76. Stringa E, Filanti C, Giunciuglio D, Albini A, Manduca P. Osteoblastic cells from rat long
bone. I. Characterization of their differentiation in culture. Bone. 16:663-70; 1995. IF=3,939
77. Albini A, Aluigi M, Benelli R, Berti E, Biberfeld P, Blasig C, Calabrò ML, Calvo F, Chieco–
Bianchi L, Corbellino M, Mistro AD, Ekman M, Favero A, Hofschneider PH, Kaaya E, Lebbé
C, Morel P, Neipel F, Noonan D, Parravicini C, Repetto L, Schalling M, Stürzl M, Tschachler
A. Oncogenesis in HIV Infection: HSHV and Kaposi'sarcoma. Int J Oncol. 9:5–8; 1996.
IF=2,681
78. Albini A, Benelli R, Presta M, Rusnati M, Ziche M, Rubartelli A, Paglialunga G, Bussolino F,
Noonan D. HIV-tat protein is a heparin-binding angiogenic growth factor. Oncogene. 12:28997.; 1996. IF=6,872
79. Albini A, Soldi R, Giunciuglio D, Giraudo E, Benelli R, Primo L, Noonan D, Salio M, Camussi
G, Rockl W, Bussolino F. The angiogenesis induced by HIV-1 tat protein is mediated by the
Flk- 1/KDR receptor on vascular endothelial cells. Nat Med. 2:1371-5.; 1996. IF=28,878
80. Aluigi MG, Albini A, Carlone S, Repetto L, De Marchi R, Icardi A, Moro M, Noonan D,
Benelli R. KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and
Mediterranean forms of Kaposi's sarcoma. Res Virol. 147:267-75.; 1996. IF=3,154
81. Aluigi MG, Cai T, Gentleman S, Wong P, Albini A, Noonan DM, Fassina G. Induction of
differentiation and apoptosis in retinoblastoma cells by cAMP analogs and laminin. Fund Clin
Immun. 4 suppl:23–5; 1996. IF=0,857
82. Benelli R, Albini A, Parravicini C, Carlone S, Repetto L, Tambussi G, Lazzarin A. Isolation of
spindle-shaped cell populations from primary cultures of Kaposi's sarcoma of different stage.
Cancer Lett. 100:125-32.; 1996. IF=3,049
83. Bussolino F, Albini A, Camussi G, Presta M, Viglietto G, Ziche M, Persico G. Role of soluble
mediators in angiogenesis. Eur J Cancer. 32A:2401-12.; 1996. IF=3,706
84. Corallini A, Campioni D, Rossi C, Albini A, Possati L, Rusnati M, Gazzanelli G, Benelli R,
Masiello L, Sparacciari V, Presta M, Mannello F, Fontanini G, Barbanti-Brodano G. Promotion
of tumour metastases and induction of angiogenesis by native HIV-1 Tat protein from BK
virus/tat transgenic mice. Aids. 10:701-10; 1996. IF=5,835
85. Cornali E, Zietz C, Benelli R, Weninger W, Masiello L, Breier G, Tschachler E, Albini A,
Sturzl M. Vascular endothelial growth factor regulates angiogenesis and vascular permeability
in Kaposi's sarcoma. Am J Pathol. 149:1851-69.; 1996. IF=5,796
86. De Flora S, D'Agostini F, Masiello L, Giunciuglio D, Albini A. Synergism between Nacetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine
models. Int J Cancer. 67:842-8.; 1996. IF=2,681
87. Fassina G, Paglialunga G, Fontanini G, Cosimi A, Perrotta A, Ardizzoni A, Aluigi MG, Albini
A. Expression of mRNA for gelatinase A and TIMP-2 in cell cultures and tissues samples
derived from breast and lung carcinomas. Int J Oncol. 8:253–61; 1996. IF=2,681
88. Gualandris A, Rusnati M, Belleri M, Molinari–Tosatti MP, Bonardi F, Albini A, Ziche M,
Presta M. Angiogenic phenotype induced by basic fibroblast growth ractor transfection in brain
microvascular endothelial cells: an in vitro autocrine model of angiogenesis in brain tumors. Int
J Oncol. 8:567–73; 1996. IF=2,681
89. Gualandris A, Rusnati M, Belleri M, Nelli EE, Bastaki M, Molinari-Tosatti MP, Bonardi F,
Parolini S, Albini A, Morbidelli L, Ziche M, Corallini A, Possati L, Vacca A, Ribatti D, Presta
M. Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism
for angiogenesis and angioproliferative diseases. Cell Growth Differ. 7:147-60; 1996. IF=3,826
90. Maier JA, Mariotti M, Albini A, Comi P, Prat M, Comogilio PM, Soria MR. Over-expression
of hepatocyte growth factor in human Kaposi's sarcoma. Int J Cancer. 65:168-72; 1996.
IF=4,700
91. Monini P, Rotola A, de Lellis L, Corallini A, Secchiero P, Albini A, Benelli R, Parravicini C,
Barbanti-Brodano G, Cassai E. Latent BK virus infection and Kaposi's sarcoma pathogenesis.
Int J Cancer. 66:717-22; 1996. IF=4,700
92. Valente P, Melchiori A, Paggi MG, Masiello L, Ribatti D, Santi L, Takahashi R, Albini A,
Noonan DM. RB1 oncosuppressor gene over-expression inhibits tumor progression and induces
melanogenesis in metastatic melanoma cells. Oncogene. 13:1169-78.; 1996. IF=6,872
93. Valente P, Noonan DM, Ogle RC, Albini A. Altered production of laminin and nidogen by high
and low metastatic variants of murine melanoma cells. Oncol Res. 8:131-8; 1996. IF=1,844
94. Adatia R, Albini A, Carlone S, Giunciuglio D, Benelli R, Santi L, Noonan DM. Suppression of
invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA. Ann
Oncol. 8:1257-61; 1997. IF=4,319
95. Albini A, Paglieri I, Orengo G, Carlone S, Aluigi MG, DeMarchi R, Matteucci C, Mantovani
A, Carozzi F, Donini S, Benelli R. The beta-core fragment of human chorionic gonadotrophin
inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma
cell line. Aids. 11:713-21.; 1997. IF=5,835
96. Benelli R, Masiello L, Paglialunga G, Noonan DM, Repetto L, Carlone S, Orengo G, Fontanini
G, Albini A. IFNalpha inhibits tat–induced angiogenesis. In: Guenounou M, editor. Research in
Hiv and Cytokines. Paris: INSERM; 1997. p. 447–58.
97. Carlevaro MF, Albini A, Ribatti D, Gentili C, Benelli R, Cermelli S, Cancedda R, Cancedda
FD. Transferrin promotes endothelial cell migration and invasion: implication in cartilage
neovascularization. J Cell Biol. 136:1375-84.; 1997. IF=10,951
98. Fassina G, Aluigi MG, Gentleman S, Wong P, Cai T, Albini A, Noonan DM. The cAMP
analog 8-Cl-cAMP inhibits growth and induces differentiation and apoptosis in retinoblastoma
cells. Int J Cancer. 72:1088-94.; 1997. IF=4,700
99. Gualandris A, Lopez Conejo T, Giunciuglio D, Albini A, Sabini E, Rusnati M, Dell'Era P,
Presta M. Urokinase-type plasminogen activator overexpression enhances the invasive capacity
of endothelial cells. Microvasc Res. 53:254-60.; 1997. IF=2,362
100.
Lang ME, Lottersberger C, Roth B, Bock G, Recheis H, Sgonc R, Sturzl M, Albini A,
Tschachler E, Zangerle R, Donini S, Feichtinger H, Schwarz S. Induction of apoptosis in
Kaposi's sarcoma spindle cell cultures by the subunits of human chorionic gonadotropin. Aids.
11:1333-40.; 1997. IF=5,835
101.
Loprevite M, Varesco L, Favoni R, Ferrara GB, Moro F, Ottaggio L, Fronza G,
Campomenosi P, Abbondandolo A, Cutrona G, Roncella S, Albini A, Aluigi MG, Pozzi S, Pera
C, Biticchi R, Gismondi V, Grossi F, Pennucci M, Ardizzoni A. Analysis of K– ras, p53, bcl–2
and Rb expression in non–small cell lung cancer cell lines. Int J Oncol. 11:1203–08; 1997.
IF=2,681
102.
Rusnati M, Coltrini D, Oreste P, Zoppetti G, Albini A, Noonan D, di Fagagna F, Giacca
M, Presta M. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure,
sulfation, and size. J Biol Chem. 272:11313-20.; 1997. IF=5,854
103.
Albini A. Tumor and endothelial cell invasion of basement membranes. The matrigel
chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol Oncol Res. 4:23041; 1998. IF=1,162
104.
Albini A, Benelli R, Giunciuglio D, Cai T, Mariani G, Ferrini S, Noonan DM.
Identification of a novel domain of HIV tat involved in monocyte chemotaxis. J Biol Chem.
273:15895-900.; 1998. IF=5,854
105.
Albini A, Ferrini S, Benelli R, Sforzini S, Giunciuglio D, Aluigi MG, Proudfoot AE,
Alouani S, Wells TN, Mariani G, Rabin RL, Farber JM, Noonan DM. HIV-1 Tat protein
mimicry of chemokines. Proc Natl Acad Sci U S A. 95:13153-8; 1998. IF=10,231
106.
Benelli R, Mortarini R, Anichini A, Giunciuglio D, Noonan DM, Montalti S, Tacchetti
C, Albini A. Monocyte-derived dendritic cells and monocytes migrate to HIV-Tat RGD and
basic peptides. Aids. 12:261-8.; 1998. IF=5,835
107.
D'Agostini F, Bagnasco M, Giunciuglio D, Albini A, De Flora S. Inhibition by oral Nacetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary
tumors and lung micrometastases in mice. Int J Oncol. 13:217-24; 1998. IF=2,681
108.
Festuccia C, Guerra F, D'Ascenzo S, Giunciuglio D, Albini A, Bologna M. In vitro
regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Int J
Cancer. 75:418-31.; 1998. IF=4,700
109.
Iurlaro M, Benelli R, Masiello L, Rosso M, Santi L, Albini A. beta Interferon inhibits
HIV-1 Tat-induced angiogenesis: synergism with 13-cis retinoic acid. Eur J Cancer. 34:570-6.;
1998. IF=3,706
110.
Noonan D, Albini A. Anti-KS activity still a mystery [Letter]. Nat Med. 4:748.; 1998.
IF=28,878
111.
Vacca A, Ribatti D, Iurlaro M, Albini A, Minischetti M, Bussolino F, Pellegrino A, Ria
R, Rusnati M, Presta M, Vincenti V, Persico MG, Dammacco F. Human lymphoblastoid cells
produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation,
migration, morphogenesis, and angiogenesis. Int J Clin Lab Res. 28:55-68; 1998. IF=1,039
112.
Valente P, Fassina G, Melchiori A, Masiello L, Cilli M, Vacca A, Onisto M, Santi L,
Stetler-Stevenson WG, Albini A. TIMP-2 over-expression reduces invasion and angiogenesis
and protects B16F10 melanoma cells from apoptosis. Int J Cancer. 75:246-53.; 1998. IF=4,700
113.
Albini A, Florio T, Giunciuglio D, Masiello L, Carlone S, Corsaro A, Thellung S, Cai T,
Noonan DM, Schettini G. Somatostatin controls Kaposi's sarcoma tumor growth through
inhibition of angiogenesis. Faseb J. 13:647-55.; 1999. IF=7,064
114.
Albini A, Noonan D, Santi L. Angiogenesis at the interface between basic and clinical
research. Int J Biol Markers. 14:202-6.; 1999. IF=1,098
115.
Basolo F, Fiore L, Fusco A, Giannini R, Albini A, Merlo GR, Fontanini G, Conaldi PG,
Toniolo A. Potentiation of the malignant phenotype of the undifferentiated ARO thyroid cell
line by insertion of the bcl-2 gene. Int J Cancer. 81:956-62.; 1999. IF=4,700
116.
Benelli R, Albini A. In vitro models of angiogenesis: the use of Matrigel. Int J Biol
Markers. 14:243-6.; 1999. IF=1,098
117.
Biancone L, Cantaluppi V, Boccellino M, Bussolati B, Del Sorbo L, Conaldi PG, Albini
A, Toniolo A, Camussi G. Motility induced by human immunodeficiency virus-1 Tat on
Kaposi's sarcoma cells requires platelet-activating factor synthesis. Am J Pathol. 155:1731-9.;
1999. IF=5,796
118.
Biancone L, Cantaluppi V, Boccellino M, Del Sorbo L, Russo S, Albini A, Stamenkovic
I, Camussi G. Activation of CD40 favors the growth and vascularization of Kaposi's sarcoma. J
Immunol. 163:6201-8.; 1999. IF=6,387
119.
Cai T, Fassina G, Morini M, Aluigi MG, Masiello L, Fontanini G, D'Agostini F, De
Flora S, Noonan DM, Albini A. N-acetylcysteine inhibits endothelial cell invasion and
angiogenesis. Lab Invest. 79:1151-9.; 1999. IF=4,165
120.
Coulibaly S, Schwihla H, Abrahamson M, Albini A, Cerni C, Clark JL, Ng KM,
Katunuma N, Schlappack O, Glossl J, Mach L. Modulation of invasive properties of murine
squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J
Cancer. 83:526-31.; 1999. IF=4,700
121.
Festuccia C, Giunciuglio D, Guerra F, Villanova I, Angelucci A, Manduca P, Teti A,
Albini A, Bologna M. Osteoblasts modulate secretion of urokinase-type plasminogen activator
(uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting
migration and matrigel invasion. Oncol Res. 11:17-31; 1999. IF=1,844
122.
Garbisa S, Biggin S, Cavallarin N, Sartor L, Benelli R, Albini A. Tumor invasion:
molecular shears blunted by green tea. Nat Med. 5:1216.; 1999. IF=28,878
123.
Indraccolo S, Minuzzo S, Gola E, Habeler W, Carrozzino F, Noonan D, Albini A, Santi
L, Amadori A, Chieco-Bianchi L. Generation of expression plasmids for angiostatin, endostatin
and TIMP- 2 for cancer gene therapy. Int J Biol Markers. 14:251-6.; 1999. IF=1,098
124.
Marchio S, Primo L, Pagano M, Palestro G, Albini A, Veikkola T, Cascone I, Alitalo K,
Bussolino F. Vascular endothelial growth factor-C stimulates the migration and proliferation of
Kaposi's sarcoma cells. J Biol Chem. 274:27617-22.; 1999. IF=5,854
125.
Marchisone C, Benelli R, Albini A, Santi L, Noonan DM. Inhibition of angiogenesis by
type I interferons in models of Kaposi's sarcoma. Int J Biol Markers. 14:257-62.; 1999.
IF=1,098
126.
Marconcini L, Marchio S, Morbidelli L, Cartocci E, Albini A, Ziche M, Bussolino F,
Oliviero S. c-fos-induced growth factor/vascular endothelial growth factor D induces
angiogenesis in vivo and in vitro. Proc Natl Acad Sci U S A. 96:9671-6.; 1999. IF=10,789
127.
Morini M, Cai T, Aluigi MG, Noonan DM, Masiello L, De Flora S, D'Agostini F, Albini
A, Fassina G. The role of the thiol N-acetylcysteine in the prevention of tumor invasion and
angiogenesis. Int J Biol Markers. 14:268-71.; 1999. IF=1,098
128.
Taraboletti G, Benelli R, Borsotti P, Rusnati M, Presta M, Giavazzi R, Ruco L, Albini
A. Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat- induced
angiogenesis and is poorly expressed in KS lesions. J Pathol. 188:76-81.; 1999. IF=6,213
129.
Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R, Albini A, Bussolino F,
Dammacco F. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix
metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood.
93:3064-73.; 1999. IF=10,131
130.
Albini A, Marchisone C, Del Grosso F, Benelli R, Masiello L, Tacchetti C, Bono M,
Ferrantini M, Rozera C, Truini M, Belardelli F, Santi L, Noonan DM. Inhibition of
angiogenesis and vascular tumor growth by interferon- producing cells: A gene therapy
approach. Am J Pathol. 156:1381-93.; 2000. IF=5,796
131.
Aluigi MG, De Flora S, D'Agostini F, Albini A, Fassina G. Antiapoptotic and
antigenotoxic effects of N-acetylcysteine in human cells of endothelial origin. Anticancer Res.
20:3183-7.; 2000. IF=1,604
132.
Benelli R, Barbero A, Buffa A, Aluigi MG, Masiello L, Morbidelli L, Ziche M, Albini
A, Noonan D. Distinct chemotactic and angiogenic activities of peptides derived from Kaposi's
sarcoma virus encoded chemokines. Int J Oncol. 17:75-81.; 2000. IF=2,681
133.
Benelli R, Barbero A, Ferrini S, Scapini P, Cassatella M, Bussolino F, Tacchetti C,
Noonan DM, Albini A. Human immunodeficiency virus transactivator protein (Tat) stimulates
chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes:
implications for Tat-mediated pathogenesis. J Infect Dis. 182:1643-51.; 2000. IF=4,953
134.
Biroccio A, Candiloro A, Mottolese M, Sapora O, Albini A, Zupi G, Del Bufalo D. Bcl2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor
expression and in vivo angiogenesis in a breast carcinoma line. Faseb J. 14:652-60.; 2000.
IF=7,064
135.
Di Carlo E, Comes A, Basso S, De Ambrosis A, Meazza R, Musiani P, Moelling K,
Albini A, Ferrini S. The combined action of IL-15 and IL-12 gene transfer can induce tumor
cell rejection without T and NK cell involvement. J Immunol. 165:3111-8.; 2000. IF=6,387
136.
Fassina G, Ferrari N, Brigati C, Benelli R, Santi L, Noonan DM, Albini A. Tissue
inhibitors of metalloproteases: regulation and biological activities. Clin Exp Metastasis. 18:11120; 2000. IF=2,811
137.
Festuccia C, Angelucci A, Gravina GL, Villanova II, Teti A, Albini A, Bologna M.
Osteoblast-derived TGFbeta-1 modulates matrix degrading protease expression and activity in
prostate cancer cells. Int J Cancer. 86:888; 2000. IF=4,700
138.
Ghezzi S, Noonan DM, Aluigi MG, Vallanti G, Cota M, Benelli R, Morini M, Reeves
JD, Vicenzi E, Poli G, Albini A. Inhibition of CXCR4-dependent HIV-1 infection by
extracellular HIV-1 Tat. Biochem Biophys Res Commun. 270:992-6.; 2000. IF=3,000
139.
Giavazzi R, Albini A, Bussolino F, DeBraud F, Presta M, Ziche M, Costa A. The
biological basis for antiangiogenic therapy. Eur J Cancer. 36:1913-8.; 2000. IF=3,706
140.
Marchisone C, Pfeffer U, Del Grosso F, Noonan DM, Santi L, Albini A. Progress
towards gene therapy for cancer. J Exp Clin Cancer Res. 19:261-70.; 2000. IF=0,540
141.
Montaldo F, Maffe A, Morini M, Noonan D, Giordano S, Albini A, Prat M. Expression
of functional tyrosine kinases on immortalized Kaposi's sarcoma cells. J Cell Physiol. 184:24654.; 2000. IF=4,362
142.
Morini M, Benelli R, Giunciuglio D, Carlone S, Arena G, Noonan DM, Albini A.
Kaposi's sarcoma cells of different etiologic origins respond to HIV- Tat through the Flk1/KDR (VEGFR-2): relevance in AIDS-KS pathology. Biochem Biophys Res Commun.
273:267-71.; 2000. IF=3,000
143.
Morini M, Mottolese M, Ferrari N, Ghiorzo F, Buglioni S, Mortarini R, Noonan DM,
Natali PG, Albini A. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell
metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer. 87:336-42.; 2000.
IF=4,700
144.
Noonan DM, Albini A. From the outside in: extracellular activities of HIV Tat. In:
Jeang KT, editor. HIV: Molecular Mechanisms and Clinical Applications. San Diego, CA:
Academic Press; 2000. p. 229-50.
145.
Rusnati M, Taraboletti G, Urbinati C, Tulipano G, Giuliani R, Molinari-Tosatti MP,
Sennino B, Giacca M, Tyagi M, Albini A, Noonan D, Giavazzi R, Presta M. Thrombospondin1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat. Faseb
J. 14:1917-30; 2000. IF=7,064
146.
Tosi G, Meazza R, De Lerma Barbaro A, D'Agostino A, Mazza S, Corradin G, Albini
A, Noonan DM, Ferrini S, Accolla RS. Highly stable oligomerization forms of HIV-1 Tat
detected by monoclonal antibodies and requirement of monomeric forms for the transactivating
function on the HIV-1 LTR. Eur J Immunol. 30:1120-6.; 2000. IF=4,876
147.
Vene R, Benelli R, Noonan DM, Albini A. HIV-Tat dependent chemotaxis and
invasion, key aspects of tat mediated pathogenesis. Clin Exp Metastasis. 18:533-8; 2000.
IF=2,811
148.
Albini A, Morini M, D'Agostini F, Ferrari N, Campelli F, Arena G, Noonan DM, Pesce
C, De Flora S. Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice
by oral N-acetylcysteine. Cancer Res. 61:8171-8; 2001. IF=7,616
149.
Bagnato A, Rosano L, Di Castro V, Albini A, Salani D, Varmi M, Nicotra MR, Natali
PG. Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells. Am J Pathol.
158:841-7.; 2001. IF=5,796
150.
Barbero A, Benelli R, Minghelli S, Tosetti F, Dorcaratto A, Ponzetto C, Wernig A,
Cullen MJ, Albini A, Noonan DM. Growth factor supplemented matrigel improves ectopic
skeletal muscle formation--a cell therapy approach. J Cell Physiol. 186:183-92.; 2001. IF=4,362
151.
Bonavia R, Bajetto A, Barbero S, Albini A, Noonan DM, Schettini G. HIV-1 Tat causes
apoptotic death and calcium homeostasis alterations in rat neurons. Biochem Biophys Res
Commun. 288:301-8.; 2001. IF=3,000
152.
Cantaluppi V, Biancone L, Boccellino M, Doublier S, Benelli R, Carlone S, Albini A,
Camussi G. Hiv type 1 tat protein is a survival factor for kaposi's sarcoma and endothelial cells.
AIDS Res Hum Retroviruses. 17:965-76.; 2001. IF=2,531
153.
Casalone R, Albini A, Righi R, Granata P, Toniolo A. Nonrandom chromosome changes
in Kaposi sarcoma: cytogenetic and FISH results in a new cell line (KS-IMM) and literature
review. Cancer Genet Cytogenet. 124:16-9.; 2001. IF=1,640
154.
Corsaro A, Thellung S, Villa V, Arena S, Noonan D, Albini A, Schettini G, Florio T.
Somatostatinergic control of Kaposi's sarcoma growth through the inhibition of angiogenesis.
Minerva Endocrinol. 26:273-6.; 2001.
155.
De Flora S, Izzotti A, D'Agostini F, Balansky RM, Noonan D, Albini A. Multiple points
of intervention in the prevention of cancer and other mutation-related diseases. Mutat Res. 480481:9-22.; 2001. IF=3,340
156.
Fazekas K, Janovics A, Dome B, Koska P, Albini A, Timar J. Effect of HGF-like basic
hexapeptides on angiogenesis. Microvasc Res. 62:440-4.; 2001. IF=2,362
157.
Garbisa S, Sartor L, Biggin S, Salvato B, Benelli R, Albini A. Tumor gelatinases and
invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer. 91:822-32;
2001. IF=4,800
158.
Indraccolo S, Morini M, Gola E, Carrozzino F, Habeler W, Minghelli S, Santi L,
Chieco-Bianchi L, Cao Y, Albini A, Noonan DM. Effects of angiostatin gene transfer on
functional properties and in vivo growth of kaposi's sarcoma cells. Cancer Res. 61:5441-6.;
2001. IF=7,616
159.
Lorusso G, Dell'Eva R, Vene R, Pfeffer U, Albini A. Rationale, problems and
perspectives in anti-angiogenic therapy. Tumori. 87:S17-9.; 2001.
160.
Rusnati M, Urbinati C, Musulin B, Ribatti D, Albini A, Noonan D, Marchisone C,
Waltenberger J, Presta M. Activation of endothelial cell mitogen activated protein kinase
ERK(1/2) by extracellular HIV-1 Tat protein. Endothelium. 8:65-74; 2001. IF=2,343
161.
Baldi A, De Luca A, Morini M, Battista T, Felsani A, Baldi F, Catricala C, Amantea A,
Noonan DM, Albini A, Natali PG, Lombardi D, Paggi MG. The HtrA1 serine protease is downregulated during human melanoma progression and represses growth of metastatic melanoma
cells. Oncogene. 21:6684-8.; 2002. IF=6,872
162.
Benelli R, Morini M, Carrozzino F, Ferrari N, Minghelli S, Santi L, Cassatella M,
Noonan DM, Albini A. Neutrophils as a key cellular target for angiostatin: implications for
regulation of angiogenesis and inflammation. Faseb J. 16:267-9.; 2002. IF=7,064
163.
Benelli R, Vene R, Bisacchi D, Garbisa S, Albini A. Anti-invasive effects of green tea
polyphenol epigallocatechin-3- gallate (EGCG), a natural inhibitor of metallo and serine
proteases. Biol Chem. 383:101-5.; 2002. IF=2,577
164.
Bisacchi D, Noonan DM, Carlone S, Albini A, Pfeffer U. Kaposi's sarcoma and human
chorionic gonadotropin: mechanisms, moieties and mysteries. Biol Chem. 383:1315-20.; 2002.
165.
Brigati C, Noonan DM, Albini A, Benelli R. Tumors and inflammatory infiltrates:
friends or foes? Clin Exp Metastasis. 19:247-58; 2002. IF=2,811
166.
Cassoni P, Sapino A, Deaglio S, Bussolati B, Volante M, Munaron L, Albini A, Torrisi
A, Bussolati G. Oxytocin Is a Growth Factor for Kaposi's Sarcoma Cells: Evidence of
Endocrine-Immunological Cross-Talk. Cancer Res. 62:2406-13.; 2002. IF=7,616
167.
Dell'Eva R, Pfeffer U, Indraccolo S, Albini A, Noonan D. Inhibition of tumor
angiogenesis by angiostatin: from recombinant protein to gene therapy. Endothelium. 9:3-10;
2002. IF=2,343
168.
Deregibus MC, Cantaluppi V, Doublier S, Brizzi MF, Deambrosis I, Albini A, Camussi
G. HIV-1-Tat protein activates phosphatidylinositol 3-kinase/ AKT- dependent survival
pathways in Kaposi's sarcoma cells. J Biol Chem. 277:25195-202.; 2002. IF=5,854
169.
Fassina G, Buffa A, Benelli R, Varnier OE, Noonan DM, Albini A. Polyphenolic
antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. Aids.
16:939-41.; 2002. IF=5,835
170.
Giannelli G, Astigiano S, Antonaci S, Morini M, Barbieri O, Noonan DM, Albini A.
Role of the alpha3beta1 and alpha6beta4 integrins in tumor invasion. Clin Exp Metastasis.
19:217-23; 2002. IF=2,811
171.
Indraccolo S, Gola E, Rosato A, Minuzzo S, Habeler W, Tisato V, Roni V, Esposito G,
Morini M, Albini A, Noonan DM, Ferrantini M, Amadori A, Chieco-Bianchi L. Differential
effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of
human breast cancer cells. Gene Ther. 9:867-78.; 2002. IF=4,836
172.
Lollini PL, Pierotti MA, Passerini CG, Bani MR, Zupi G, Aglietta M, Albini A.. New
challenges of molecular oncology. Tumori. 88:77-81.; 2002.
173.
Pfeffer U, Bisacchi D, Morini M, Benelli R, Minghelli S, Vacca A, Noonan DM, Albini
A. Human chorionic gonadotropin inhibits Kaposi's sarcoma associated angiogenesis, matrix
metalloprotease activity, and tumor growth. Endocrinology. 143:3114-21; 2002. IF=5,313
174.
Scapini P, Nesi L, Morini M, Tanghetti E, Belleri M, Noonan D, Presta M, Albini A,
Cassatella MA. Generation of biologically active angiostatin kringle 1-3 by activated human
neutrophils. J Immunol. 168:5798-804.; 2002. IF=6,387
175.
Tosetti F, Benelli R, Albini A. The angiogenic switch in solid tumors: clinical
implications. Suppl Tumori. 1:S9-11.; 2002. IF=0,739
176.
Tosetti F, Ferrari N, De Flora S, Albini A. Angioprevention': angiogenesis is a common
and key target for cancer chemopreventive agents. Faseb J. 16:2-14.; 2002. IF=7,064
177.
Benelli R, Albini A, Noonan D. Neutrophils and angiogenesis: potential initiators of the
angiogenic cascade. Chem Immunol Allergy. 83:167-81; 2003.
178.
Benelli R, Morini M, Brigati C, Noonan DM, Albini A. Angiostatin inhibits
extracellular HIV-Tat-induced inflammatory angiogenesis. Int J Oncol. 22:87-91.; 2003.
IF=2,571
179.
Benelli R, Peissel B, Manenti G, Gariboldi M, Vanzetto C, Albini A, Dragani TA.
Allele-specific patterns of the mouse parathyroid hormone-related protein: influences on cell
adhesion and migration. Oncogene. 22:7711-5; 2003. IF=7,414
180.
Bisacchi D, Benelli R, Vanzetto C, Ferrari N, Tosetti F, Albini A. Anti-angiogenesis and
angioprevention: mechanisms, problems and perspectives. Cancer Detect Prev. 27:229-38.;
2003. IF=1,918
181.
Borghi R, Vene R, Arena G, Schubert D, Albini A, Tosetti F. Transient modulation of
cytoplasmic and nuclear retinoid receptors expression in differentiating human teratocarcinoma
NT2 cells. J Neurochem. 84:94-104.; 2003. IF=4,337
182.
Brigati C, Giacca M, Noonan DM, Albini A. HIV Tat, its TARgets and the control of
viral gene expression. FEMS Microbiol Lett. 220:57-65.; 2003. IF=2,04
183.
Donà M, Dell'Aica I, Calabrese F, Benelli R, Morini M, Albini A, Garbisa S. Neutrophil
restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary
fibrosis. J Immunol. 170:4335-41.; 2003. IF=5,745
184.
Ferrari N, Morini M, Pfeffer U, Minghelli S, Noonan DM, Albini A. Inhibition of
Kaposi's Sarcoma in Vivo by Fenretinide. Clin Cancer Res. 9:6020-9; 2003. IF=7,338
185.
Ferrari N, Paleari L, Palmisano GL, Tammaro P, Levi G, Albini A, Brigati C. Induction
of apoptosis by fenretinide in tumor cell lines correlates with DLX2, DLX3 and DLX4 gene
expression. Oncol Rep. 10:973-7.; 2003. IF=1,686
186.
Ferrari N, Palmisano GL, Paleari L, Basso G, Mangioni M, Fidanza V, Albini A, Croce
CM, Levi G, Brigati C. DLX genes as targets of ALL-1: DLX 2,3,4 down-regulation in t(4;11)
acute lymphoblastic leukemias. J Leukoc Biol. 74:302-5; 2003. IF=4,626
187.
Florio T, Morini M, Villa V, Arena S, Corsaro A, Thellung S, Culler MD, Pfeffer U,
Noonan DM, Schettini G, Albini A. Somatostatin inhibits tumor angiogenesis and growth via
somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogenactivated protein kinase activities. Endocrinology. 144:1574-84.; 2003. IF=4,993
188.
Giunti D, Borsellino G, Benelli R, Marchese M, Capello E, Valle MT, Pedemonte E,
Noonan D, Albini A, Bernardi G, Mancardi GL, Battistini L, Uccelli A. Phenotypic and
functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the
CNS. J Leukoc Biol. 73:584-90.; 2003. IF=4,626
189.
Guenzi E, Topolt K, Lubeseder-Martellato C, Jorg A, Naschberger E, Benelli R, Albini
A, Sturzl M. The guanylate binding protein-1 GTPase controls the invasive and angiogenic
capability of endothelial cells through inhibition of MMP-1 expression. Embo J. 22:3772-82;
2003. IF=10,124
190.
Noonan DM, Gringeri A, Meazza R, Rosso O, Mazza S, Muca-Perja M, Le Buanec H,
Accolla RS, Albini A, Ferrini S. Identification of immunodominant epitopes in inactivated Tatvaccinated healthy and HIV-1-infected volunteers. J Acquir Immune Defic Syndr. 33:47-55.;
2003. IF=4,262
191.
Pezzato E, Dona M, Sartor L, Dell'Aica I, Benelli R, Albini A, Garbisa S. Proteinase-3
directly activates MMP-2 and degrades gelatin and Matrigel; differential inhibition by ()epigallocatechin-3-gallate. J Leukoc Biol. 74:88-94; 2003. IF=4,626
192.
Pfeffer U, Ferrari N, Morini M, Benelli R, Noonan DM, Albini A. Antiangiogenic
activity of chemopreventive drugs. Int J Biol Markers. 18:70-4.; 2003. IF=1,26
193.
Pfeffer U, Noonan D, Albini A. Re: Microarray studies challenge theories of metastasis.
J Natl Cancer Inst. 95:829; 2003. IF=14,697
194.
Rosano L, Spinella F, Di Castro V, Nicotra MR, Albini A, Natali PG, Bagnato A.
Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and
tumor growth in vivo. Am J Pathol. 163:753-62; 2003. IF=5,224
195.
Tosetti F, Vene R, Arena G, Morini M, Minghelli S, Noonan DM, Albini A. N-(4hydroxyphenyl)retinamide inhibits retinoblastoma growth through reactive oxygen speciesmediated cell death. Mol Pharmacol. 63:565-73.; 2003. IF=4,725
196.
Albini A, Benelli R, Noonan DM, Brigati C. The "chemoinvasion assay": a tool to study
tumor and endothelial cell invasion of basement membranes. Int J Dev Biol. 48:563-71; 2004.
IF=2,856
197.
Fassina G, Vene R, Morini M, Minghelli S, Benelli R, Noonan DM, Albini A.
Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by
epigallocatechin-3-gallate. Clin Cancer Res. 10:4865-73; 2004. IF=7,338
198.
Forster-Horvath C, Meszaros L, Raso E, Dome B, Ladanyi A, Morini M, Albini A,
Timar J. Expression of CD44v3 protein in human endothelial cells in vitro and in tumoral
microvessels in vivo. Microvasc Res. 68:110-8; 2004. IF=2,39
199.
Morini M, Albini A, Lorusso G, Moelling K, Lu B, Cilli M, Ferrini S, Noonan DM.
Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by
immunogene therapy. Gene Ther. 11:284-91; 2004. IF=4,538
200.
Morini M, Roccatagliata L, Dell'Eva R, Pedemonte E, Furlan R, Minghelli S, Giunti D,
Pfeffer U, Marchese M, Noonan D, Mancardi G, Albini A, Uccelli A. Alpha-lipoic acid is
effective in prevention and treatment of experimental autoimmune encephalomyelitis. J
Neuroimmunol. 148:146-53; 2004. IF=2,901
201.
Raso E, Meszaros L, Albini A, Timar J. A WT1 expressing metastatic human Kaposi
sarcoma xenograft model. Pathol Oncol Res. 10:22-5; 2004. IF=1,483
202.
Rossello A, Nuti E, Orlandini E, Carelli P, Rapposelli S, Macchia M, Minutolo F,
Carbonaro L, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A. New N-arylsulfonylN-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2). Bioorg
Med Chem. 12:2441-50; 2004. IF=2,978
203.
Sartor L, Pezzato E, Dona M, Dell'Aica I, Calabrese F, Morini M, Albini A, Garbisa S.
Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered
MMP-2 activation and invasion in murine TRAMP model. Int J Cancer. 112:823-9; 2004.
IF=4,926
204.
Scapini P, Morini M, Tecchio C, Minghelli S, Di Carlo E, Tanghetti E, Albini A, Lowell
C, Berton G, Noonan DM, Cassatella MA. CXCL1/macrophage inflammatory protein-2induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth
factor-A. J Immunol. 172:5034-40; 2004. IF=5,745
205.
Dell’Eva R, Pfeffer U, Vené R, Anfosso L, Forlani A, Albini A, Efferth T. Inhibition of
angiogenesis in vivo and growth of Kaposi’s sarcoma xenograft tumors by the anti-malarial
artesunate. Biochem Pharmacol. 68(12):2359-66; 2004. IF=4,889
206.
Zacchigna S, Zentilin L, Morini M, Dell'Eva R, Noonan DM, Albini A, Giacca M.
AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor
growth and angiogenesis in vivo. Cancer Gene Ther. 11:73-80; 2004. IF=3,744
207.
Albini A, Noonan DM. Rescuing COX-2 Inhibitors From the Waste Bin [Letter]. J Natl
Cancer Inst. Jun 1;97(11):859-60. 2005 IF=14,697
208.
Albini A, Tosetti F, Benelli R, Noonan DM. Tumor inflammatory angiogenesis and its
chemoprevention. Cancer Res. 65:10637-41; 2005. IF=8,234
209.
Bachmeier B, Vene R, Iancu C, Pfeffer U, Mayer B, Noonan D, Albini A, Jochum M,
Nerlich A. Transcriptional control of cell density dependent regulation of matrix
metalloproteinase and TIMP expression in breast cancer cell lines. Thromb Haemost. 93:761-9;
2005. IF=4,701
210.
Bachmeier BE, Albini A, Vene R, Benelli R, Noonan D, Weigert C, Weiler C,
Lichtinghagen R, Jochum M, Nerlich AG. Cell density-dependent regulation of matrix
metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines. Exp
Cell Res. 305:83-98; 2005. IF=3,609
211.
Ferrari N, Pfeffer U, Dell'Eva R, Ambrosini C, Noonan DM, Albini A. The transforming
growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory
cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide. Clin
Cancer Res. 11:4610-9; 2005. IF=7,338
212.
Margheri F, D'Alessio S, Serrati S, Pucci M, Del Rosso A, Benelli R, Ferrari N, Noonan
DM, Albini A, Fibbi G, Del Rosso M. The urokinase-type plasminogen activator, its receptor
and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary
endothelial cells: role of HIV-Tat protein. Int J Oncol. 27:223-35; 2005. IF=2,571
213.
Noonan DM, Severino A, Morini M, Tritarelli A, Manente L, D'Agnano I, Starace G,
Baldi A, Lombardi D, Albini A, Felsani A, Paggi MG. In vitro and in vivo tumor growth
inhibition by a p16-mimicking peptide in p16(INK4A)-defective, pRb-positive human
melanoma cells. J Cell Physiol. 202:922-8; 2005. IF=3,986
214.
Pfeffer U, Ferrari N, Dell'eva R, Indraccolo S, Morini M, Noonan DM, Albini A.
Molecular mechanisms of action of angiopreventive anti-oxidants on endothelial cells:
Microarray gene expression analyses. Mutat Res. 591:198-211; 2005. IF=3,204
215.
Timar J, Meszaros L, Orosz Z, Albini A, Raso E. WT1 expression in angiogenic
tumours of the skin. Histopathology. 47:67-73; 2005. IF=3,569
216.
Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M,
Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A. N-iPropoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of
MMP-2 and MT1-MMP. Bioorg. Med. Chem. Lett. 15(5):1321-6; 2005. IF=2,661
217.
Albini A, Dell'Eva R, Vene R, Ferrari N, Buhler DR, Noonan DM, Fassina G.
Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and
Akt as targets. Faseb J. 20:527-9; 2006. IF=6,515
218.
Albini A, Pfeffer U. A new tumor suppressor gene: invasion, metastasis, and
angiogenesis as potential key targets. J Natl Cancer Inst. 98:800-1; 2006. IF=14,697
219.
Anfosso L, Efferth T, Albini A, Pfeffer U. Microarray expression profiles of
angiogenesis-related genes predict tumor cell response to artemisinins. Pharmacogenomics J.
6:269-78; 2006. IF=4,306
220.
Benelli R, Lorusso G, Albini A, Noonan DM. Cytokines and chemokines as regulators
of angiogenesis in health and disease. Curr Pharm Des. 12:3101-15; 2006. IF=4,774
221.
Cantaluppi V, Deregibus MC, Biancone L, Deambrosis I, Bussolati B, Albini A,
Camussi G. The expression of CD154 by Kaposis sarcoma cells mediates the anti-apoptotic and
migratory effects of HIV-1-TAT protein. Int J Immunopathol Pharmacol. 19:81-96; 2006.
IF=2,685
222.
Cantarella G, Risuglia N, Dell'eva R, Lempereur L, Albini A, Pennisi G, Scoto GM,
Noonan DN, Bernardini R. TRAIL inhibits angiogenesis stimulated by VEGF expression in
human glioblastoma cells. Br J Cancer. 94:1428-35; 2006. IF=4,831
223.
Paleari L, Trombino S, Falugi C, Gallus L, Carlone S, Angelini C, Sepcic K, Turk T,
Faimali M, Noonan DM, Albini A. Marine sponge-derived polymeric alkylpyridinium salts as a
novel tumor chemotherapeutic targeting the cholinergic system in lung tumors. Int J Oncol.
29:1381-8; 2006. IF=2,571
224.
Spinella F, Rosano L, Decandia S, Di Castro V, Albini A, Elia G, Natali PG, Bagnato A.
Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells:
evidence for the endothelin-1 as a potential target. Exp Biol Med (Maywood). 231:1123-7;
2006. IF=2,954
225.
Spinella F, Rosano L, Di Castro V, Decandia S, Albini A, Nicotra MR, Natali PG,
Bagnato A. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and
downstream signaling pathways in ovarian carcinoma. Mol Cancer Ther. 5:1483-92; 2006.
IF=5,225
226.
Tettamanti G, Malagoli D, Benelli R, Albini A, Grimaldi A, Perletti G, Noonan DM, de
Eguileor M, Ottaviani E. Growth factors and chemokines: a comparative functional approach
between invertebrates and vertebrates. Curr Med Chem. 13:2737-50; 2006. IF=4,63
227.
Tosetti F, Noonan DM, Albini A. Choking hypoxia-inducible factor 1alpha: a novel
mechanism for connective tissue growth factor inhibition of angiogenesis. J Natl Cancer Inst.
98:946-8; 2006. IF=15,171
228.
Albini A, Benelli R. The chemoinvasion assay: a method to assess tumor and
endothelial cell invasion and its modulation. Nat Protoc. 2:504-11; 2007. IF=8,362
Albini A, Fassina G, Nicolo M, Dell'Eva R, Vene R, Cammarota R, Barberis M, Noonan
229.
DM. Inhibition of a vascular ocular tumor growth by IL-12 gene transfer. Clin Exp Metastasis.
24:485-93; 2007. IF=4,113
230.
Albini A, Noonan DM, Ferrari N. Molecular pathways for cancer angioprevention. Clin
Cancer Res. 13:4320-5; 2007. IF=7,338
231.
Albini A, Sporn MB. The tumour microenvironment as a target for chemoprevention.
Nat Rev Cancer. 7:139-47; 2007. IF=37,178
232.
Bachmeier B, Nerlich AG, Iancu CM, Cilli M, Schleicher E, Vene R, Dell'Eva R,
Jochum M, Albini A, Pfeffer U. The chemopreventive polyphenol Curcumin prevents
hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem.
19:137-52; 2007. IF=3,585
233.
Dell'Aica I, Niero R, Piazza F, Cabrelle A, Sartor L, Colalto C, Brunetta E, Lorusso G,
Benelli R, Albini A, Calabrese F, Agostini C, Garbisa S. Hyperforin blocks neutrophil
activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammationtriggered angiogenesis and lung fibrosis. J Pharmacol Exp Ther. 321:492-500; 2007. IF=4,017
234.
Dell'Eva R, Ambrosini C, Minghelli S, Noonan DM, Albini A, Ferrari N. The Akt
inhibitor deguelin, is an angiopreventive agent also acting on the NF-kappaB pathway.
Carcinogenesis. 28:404-13; 2007. IF=5,402
235.
Dell'Eva R, Ambrosini C, Vannini N, Piaggio G, Albini A, Ferrari N. AKT/NF-kappaB
inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies.
Cancer. 110:2007-11; 2007. IF=5,131
236.
Indraccolo S, Pfeffer U, Minuzzo S, Esposito G, Roni V, Mandruzzato S, Ferrari N,
Anfosso L, Dell'Eva R, Noonan DM, Chieco-Bianchi L, Albini A, Amadori A. Identification of
genes selectively regulated by IFNs in endothelial cells. J Immunol. 178:1122-35; 2007.
IF=5,74561.
237.
Larghero P, Vene R, Minghelli S, Travaini G, Morini M, Ferrari N, Pfeffer U, Noonan
DM, Albini A, Benelli R. Biological assays and genomic analysis reveal lipoic acid modulation
of endothelial cell behavior and gene expression. Carcinogenesis. 28:1008-20; 2007. IF=5,402
238.
Noonan DM, Benelli R, Albini A. Angiogenesis and cancer prevention: a vision. Recent
Results Cancer Res. 174:219-24; 2007.
239.
Secchiero P, Corallini F, Gonelli A, Dell'Eva R, Vitale M, Capitani S, Albini A, Zauli
G. Antiangiogenic activity of the MDM2 antagonist nutlin-3. Circ Res. 100:61-9; 2007.
IF=9,504
240.
Vannini N, Lorusso G, Cammarota R, Barberis M, Noonan DM, Sporn MB, Albini A.
The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent. Mol
Cancer Ther. 6:3139-46; 2007. IF=5,225
241.
Vene R, Arena G, Poggi A, D'Arrigo C, Mormino M, Noonan DM, Albini A, Tosetti F.
Novel cell death pathways induced by N-(4-hydroxyphenyl)retinamide: therapeutic
implications. Mol Cancer Ther. 6:286-98; 2007. IF=5,225
242.
Sporn MB, Libi K, Yore MM, Suh N, Albini A, Honda T, Sundararajan C, Gribble
GW. Platforms and Networks in Triterpenoid Pharmacology. Drug Dev. Res. 68:174-182; 2007.
IF=0,752
243.
Albini A. Tumor microenvironment, a dangerous society leading to cancer metastasis.
From mechanisms to therapy and prevention. Cancer Metastasis Rev. 27:3-4; 2008. IF=7,14
244.
Albini A, Mirisola V, Pfeffer U. Metastasis signatures: genes regulating tumormicroenvironment interactions predict metastatic behavior. Cancer Metastasis Rev. 27:75-83;
2008. IF=7,14
Araldi EM, Dell'aica I, Sogno I, Lorusso G, Garbisa S, Albini A. Natural and synthetic
245.
agents targeting inflammation and angiogenesis for chemoprevention of prostate cancer. Curr
Cancer Drug Targets. 8:146-55; 2008. IF=4,771
246.
Bianco R, Rosa R, Damiano V, Daniele G, Gelardi T, Garofalo S, Tarallo V, De Falco
S, Melisi D, Benelli R, Albini A, Ryan A, Ciardiello F, Tortora G. Vascular endothelial growth
factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in
human cancer cells. Clin Cancer Res. 14:5069-80; 2008. IF=7,338
247.
Liby K, Risingsong R, Royce DB, Williams CR, Yore MM, Honda T, Gribble GW,
Lamph WW, Vannini N, Sogno I, Albini A, Sporn MB. Prevention and Treatment of
Experimental Estrogen Receptor-Negative Mammary Carcinogenesis by the Synthetic
Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268. Clin Cancer Res. 14:4556-63;
2008. IF=7,338
248.
Miretti S, Roato I, Taulli R, Ponzetto C, Cilli M, Olivero M, Di Renzo MF, Godio L,
Albini A, Buracco P, Ferracini R. A mouse model of pulmonary metastasis from spontaneous
osteosarcoma monitored in vivo by luciferase imaging. PLoS ONE. 3:e1828; 2008. IF= 4,411
249.
Monteghirfo S, Tosetti F, Ambrosini C, Stigliani S, Pozzi S, Frassoni F, Fassina G,
Soverini S, Albini A, Ferrari N. Antileukemia effects of xanthohumol in Bcr/Abl-transformed
cells involve nuclear factor-kappaB and p53 modulation. Mol Cancer Ther. 7:2692-702; 2008.
IF=5,225
250.
Noonan DM, De Lerma Barbaro A, Vannini N, Mortara L, Albini A. Inflammation,
inflammatory cells and angiogenesis: decisions and indecisions. Cancer Metastasis Rev. 27:3140; 2008. IF=8,017
251.
Vannini N, Pfeffer U, Lorusso G, Noonan DM, Albini A. Endothelial cell aging and
apoptosis in prevention and disease: E-selectin expression and modulation as a model. Curr
Pharm Des. 14:221-5; 2008. IF=4,774
252.
Vene R, Larghero P, Arena G, Sporn MB, Albini A, Tosetti F. Glycogen synthase
kinase 3beta regulates cell death induced by synthetic triterpenoids. Cancer Res. 68:6987-96;
2008. IF=8,234
253.
Abbadessa G, Accolla R, Aiuti F, Albini A, Et. Al. Unsung Hero Robert C. Gallo.
Science. 323:206-7; 2009. IF= 31,364
254.
Albini A, Brigati C, Ventura A, Lorusso G, Pinter M, Morini M, Mancino A, Sica A,
Noonan DM. Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key
target. J Transl Med. 7:5; 2009. IF= 3,508
255.
Serrati S, Margheri F, Pucci M, Cantelmo AR, Cammarota R, Dotor J, Borras-Cuesta F,
Fibbi G, Albini A, Del Rosso M. TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent
angiogenesis. Biochem Pharmacol. 77:813-25; 2009. IF=4,889
256.
Sogno H, Vannini N, Lorusso G, Cammarota R, Noonan DM, Generoso L, Sporn MB,
Albini A. Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic
acid terpenoids. Recent Results Cancer Res. 181:209-12; 2009.
257.
Sogno I, Vene R, Sapienza C, Ferrari N, Tosetti F, Albini A. Anti-angiogenic properties
of chemopreventive drugs: fenretinide as a prototype. Recent Results Cancer Res. 181:71-6;
2009.
258.
Pfeffer U, Romeo F, Noonan DM, Albini A. Prediction of breast cancer metastasis by
genomic profiling: where do we stand?. Clin Exp Metastasis. 2009 Mar 24. IF= 4,113
259.
Lorusso G, Vannini N, Sogno I, Generoso L, Garbisa S, Noonan DM, Albini A.
Mechanisms of Hyperforin as an anti-angiogenic angioprevention agent. Eur J Cancer. 2009
May;45(8):1474-84. IF= 4,944
260.
Wang E, Albini A, Stroncek DF, Marincola FM. New take on comparative
immunology: relevance to immunotherapy. Immunotherapy 2009 1(3), 355-366. IF=0,542
Margheri F, Serratì S, Lapucci A, Chillà A, Giusti B, Pucci M, Torre E, Bianchini F,
261.
Calorini L, Albini A, Ventura A, Fibbi G, Del Rosso M. Systemic sclerosis-endothelial cell
antiangiogenic Pentraxin 3 and Matrix Metalloprotease 12 control human breast cancer tumor
vascolarization and development in mice. Neoplasia 2009– 10: 1106-1115;. IF=5,476
262.
Alessi P, Leali D, Camozzi M, Cantelmo A, Albini A, Presta M. Anti-FGF2 approaches
as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel
antiangiogenic FGF2-antagonist. Eur. Cytokine Netw. 2009,.20: 225-34; IF= 2,064
263.
Sogno I, Venè R, Ferrari N, De Censi A, Imperatori A, Noonan DM, Tosetti F, Albini
A. Angioprevention with fenretinide: Targeting angiogenesis in prevention and therapeutic
strategies. Crit Rev Oncol Hematol. 2009 Dec 22. IF=4,689
264.
Tosetti F, Noonan DM, Albini A. Metabolic regulation and redox activity as
mechanisms for angioprevention by dietary phytochemicals. Int J Cancer. 2009 Jun 23. IF=
4,926
265.
Albini A, Mussi V, Parodi A, Ventura A, Principi E, Tegami S, Rocchia M, Francheschi
E, Sogno I, Cammarota R, Finzi G, Sessa F, Noonan DM, Valbusa U. Interactions of singlewall carbon nanotubes with endothelial cells. Nanomedicine. 2010 Apr;6(2):277-88.. IF=4,882
266.
Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan
DM.Cardiotoxicity of anticancer drugs: the need for cardio-oncology andcardio-oncological
prevention. J Natl Cancer Inst. 2010 Jan 6;102(1):14-25. IF= 14,697
267.
Albini A, Indraccolo S, Noonan DM, Pfeffer U. Functional genomics of endothelial
cells treated with anti-angiogenic or angiopreventive drugs. Clin ExpMetastasis. 2010 Apr 10.
IF= 4,113
268.
Cantelmo AR, Cammarota R, Noonan DM, Focaccetti C, Comoglio PM, Prat M, Albini
A. Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth.
Oncogene. 2010 Sep 23;29(38):5286-98. IF= 7,414
269.
Albini A, Magnani E, Noonan DM. The tumor microenvironment: biology of a complex
cellular and tissue society. Q J Nucl Med Mol Imaging. 2010 Jun;54(3):244-8. IF=2,640
270.
Lopez NC, Valck C, Ramirez G, Rodriguez M, Ribeiro C, Orellana J, Maldonado I,
Albini A, Anacona D, Lemus D, Aguilar L, Schwaeble W, Ferreira A. Antiangiogenic and
antitumor effects of Trypanosoma cruzi Calreticulin. PLoS Negl Trop Dis. 2010 Jul
6;4(7):e730. IF=4,752
271.
Bachmeier BE, Mirisola V, Romeo F, Generoso L, Esposito A, Dell'eva R, Blengio F,
Killian PH, Albini A, Pfeffer U. Reference profile correlation reveals estrogen-like
trancriptional activity of Curcumin. Cell Physiol Biochem. 2010;26(3):471-82. IF=3,585
272.
Albini A, Timar J. Genomics of metastatic progression. Clin Exp Metastasis. 2010 Aug
14. IF=4,113
273.
Albini A, Noonan DM. The 'chemoinvasion' assay, 25 years and still going strong: the
use of reconstituted basement membranes to study cell invasion and angiogenesis. Curr Opin
Cell Biol. 2010 Oct; 22(5):677-89. IF= 13,54
274.
Molteni LP, Rampinelli I, Cergnul M, Scaglietti U, Paino AM, Noonan DM, Bucci EO,
Gottardi O, Albini A. Capecitabine in breast cancer: the issue of cardiotoxicity during
fluoropyrimidine treatment. Breast J. 2010 Sep-Oct;16 Suppl 1:S45-8. IF=1,425
275.
Cammarota R, Bertolini V, Pennesi G, Bucci EO, Gottardi O, Garlanda C, Laghi L,
Barberis MC, Sessa F, Noonan DM, Albini A. The tumor microenvironment of colo-rectal
cancer; stromal TLR-4 expression as a potential prognostic marker. J Transl Med. 2010 Nov
8;8(1):112. IF=3,508
276.
Albini A, Cesana E, Noonan DM. Cancer Stem Cells and the Tumor Microenvironment:
Soloist or Choral Singers? Curr Pharm Biotechnol. 2011 Feb 1;12(2):171-81 IF= 3,455
277.
Albini A, Donatelli F, Sessa F, Noonan DM, Tosetti F. Re: Re: Neurocognitive
Functioning in Adult Survivors of Childhood Noncentral Nervous System Cancers. JNCI,
2011. IF=14,697
278.
Baldanzi G, Pietronave S, Locarno D, Merlin S, Porporato P, Chianale F, Filigheddu N,
Cantelmo AR, Albini A, Graziani A, Prat M. Diacylglycerol kinases are essential for HGFdependent proliferation and motility of Kaposi's Sarcoma cells. Cancer Sci. 2011 Apr 7. IF=
3,846
279.
Seo DW, Saxinger WC, Guedez L, Cantelmo AR, Albini A, Stetler-Stevenson WG. An
integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and antitumorigenic activity in vivo. Peptides. 2011 Aug 16. [Epub ahead of print]IF=2,654
280.
Molteni LP, Cergnul M, Scaglietti U, Noonan DM, Bucci EO, Gottardi O, Albini A.
Response to the letter to the editor. Breast J. 2011 Sep;17(5):566-7. IF=1,425
281.
Albini A, Cesana E, Donatelli F, Cammarota R, Bucci EO, Baravelli M, Anzà C,
Noonan DM. Cardio-oncology in targeting the HER receptor family: the puzzle of different
cardiotoxicities of HER2 inhibitors. Future Cardiol. 2011 Sep;7(5):693-704.
282.
Ferrari N, Tosetti F, De Flora S, Donatelli F, Sogno I, Noonan DM, Albini A.Dietderived phytochemicals: from cancer chemoprevention to cardio-oncological prevention. Curr
Drug Targets. 2011 Dec 1;12(13):1909-24. IF=3,061
283.
Albini A, Donatelli F, Noonan D, D'Elios MM, Prisco D. Bringing new players into the
field: onco-pharmacovigilance in the era of cardio-oncology. Intern Emerg Med. 2012 Apr; 7
(2):99-101. IF=2,139
284.
Albini A, Noonan DM. Angiopoietin2 and tie2: tied to lymphangiogenesis and
lung metastasis. New perspectives in antimetastatic antiangiogenic therapy. J
Natl Cancer Inst. 2012 Mar 21;104(6):429-31.. IF=14,697
285.
Sogno I, Conti M, Consonni P, Noonan DM, Albini A. Surface-activated chemical
ionization-electrospray ionization source improves biomarker discovery with mass
spectrometry. Rapid Commun Mass Spectrom. 2012 May 30;26(10):1213-8. IF= 2,846
286.
Tarantini L, Feola M, Albini A, Gori S, Foglietta J, Cicoira MA, Pulignano G.
[Heart failure in women treated with adjuvant trastuzumab fro breast cancer]. G Ital Cardiol
(Rome). 2012 May;13(5):54-62.
287.
Solinas M, Massi P, Cantelmo A, Cattaneo M, Cammarota R, Bartolini D, Cinquina V,
Valenti M, Vicentini L, Noonan D, Albini A, Parolaro D. Cannabidiol inhibits angiogenesis by
multiple mechanisms. Br J Pharmacol. 2012 Nov;167(6):1218-31.. IF=4,409
288.
Albini A, Tosetti F, Li VW, Noonan DM, Li WW. Cancer prevention by targeting
angiogenesis. Nat Rev Clin Oncol. 2012 Sep;9(9):498-509. IF=11,963
289.
Ruggiero L. Sogno I., Focaccetti C., Bartolini D., Magnani E., Principi E., Noonan DM.,
Albini A. Effects of Diet-Derived Molecules on the Tumor Microenvironment. Current
Angiogenesis 2012 – Sept 1(3): 206-214.
290.
Albini A, Donatelli F, Focaccetti C, D'Elios MM, Noonan DM. Renal dysfunction and
increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology.
Intern Emerg Med. 2012 Oct;7(5):399-401.. IF=2,139
291.
Croci DO, Salatino M, Rubinstein N, Cerliani JP, Cavallin LE, Leung HJ, Ouyang J,
Ilarregui JM, Toscano MA, Domaica CI, Croci MC, Shipp MA, Mesri EA, Albini A,
Rabinovich GA. Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven
angiogenesis and tumorigenesis in Kaposi's sarcoma. J Exp Med. 2012 Oct 22;209(11):19852000. IF=13,853
292.
Puccio G, Brambilla P, Conti M, Bartolini D, Noonan D, Albini A Surface-activated
chemical ionization-electrospray mass spectrometry in the analysis of urinary thiodiglycolic
acid. Rapid Commun Mass Spectrom. 2013 Feb 15;27(3):476-80 IF=2,846
293.
Bruno A, Focaccetti C, Pagani A, Imperatori AS, Spagnoletti M, Rotolo N, Cantelmo
AR, Franzi F, Capella C, Ferlazzo G, Mortara L, Albini A, Noonan DM The proangiogenic
phenotype of natural killer cells in patients with non-small cell lung cancer. Neoplasia 2013.
Feb; 15: 133-42 IF=5.476.
294.
Magnani E, Farnetti E, Nicoli D, Casali B, Savoldi L, Focaccetti C, Boni C, Albini A,
Banzi M. Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase splice
site variant: the need for further revision of dose and schedule. Intern Emerg Med. 2013 Aug;
8(5): 417-23. IF=2,139
295.
Amaro AA, Esposito AI, Mirisola V, Mehilli A, Rosano C, Noonan D, Albini A, Pfeffer
U, Angelini G. Endocrine disruptor agent Nonyl phenol exerts an estrogen-like transcriptional
activity on estrogen receptor positive breast cancer cells. Curr Med Chem. 2014; 21(5):630-40.
IF=4,07
296.
Bruno A, Pagani A, Magnani E, Rossi T, Noonan DM, Cantelmo AR, Albini A
Inflammatory angiogenesis and the tumor microenvironment as targets for cancer therapy and
prevention. Cancer Treat Res. 2014;159:401-26
297.
Albini A, Rosano C, Angelini G, Amaro A, Esposito A, Noonan DM, Pfeffer U.
Exogenous Hormonal Regulation in Breast Cancer Cells by Phytoestrogens and Endocrine
Disruptors. Curr Med Chem. 2013 Nov 29. IF= 4,07
298.
Dallaglio K, Bruno A, Cantelmo AR, Esposito AI, Ruggiero L, Orecchioni S, Calleri A,
Bertolini F, Pfeffer U, Noonan DM, Albini A. PARADOXIC EFFECTS OF METFORMIN ON
ENDOTHELIAL CELLS AND ANGIOGENESIS. Carcinogenesis. 2014 Jan 13. IF=5,635
299.
Amaro A, Esposito AI, Gallina A, Nees M, Angelini G, Albini A, Pfeffer U. Validation
of proposed prostate cancer biomarkers with gene expression data: a long road to travel. Cancer
Metastasis Rev. 2014 Jan 30.IF=7,787
300.
Bruno A., Ferlazzo G., Albini A., Noonan DG. A think tank on TINK/TANKs: Tumor
Infiltrating Natural Killer cells and their role in angiogenesis and tumor progression - JNCI
2014 Submitted